2024-01-01 2024-12-31 2024-12-31 false 12017284 PROCURE MED LTD 2025-08-29 70229 false iso4217:GBP xbrli:pure 12017284 2023-12-31 12017284 2024-12-31 12017284 2024-01-01 2024-12-31 12017284 2022-12-31 12017284 2023-12-31 12017284 2023-01-01 2023-12-31 12017284 bus:SmallEntities 2024-01-01 2024-12-31 12017284 bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 12017284 bus:FullAccounts 2024-01-01 2024-12-31 12017284 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 12017284 core:WithinOneYear 2024-12-31 12017284 core:AfterOneYear 2024-12-31 12017284 core:WithinOneYear 2023-12-31 12017284 core:AfterOneYear 2023-12-31 12017284 core:ShareCapital 2024-12-31 12017284 core:SharePremium 2024-12-31 12017284 core:RevaluationReserve 2024-12-31 12017284 core:OtherReservesSubtotal 2024-12-31 12017284 core:RetainedEarningsAccumulatedLosses 2024-12-31 12017284 core:ShareCapital 2023-12-31 12017284 core:SharePremium 2023-12-31 12017284 core:RevaluationReserve 2023-12-31 12017284 core:OtherReservesSubtotal 2023-12-31 12017284 core:RetainedEarningsAccumulatedLosses 2023-12-31 12017284 core:LandBuildings 2024-12-31 12017284 core:PlantMachinery 2024-12-31 12017284 core:Vehicles 2024-12-31 12017284 core:FurnitureFittings 2024-12-31 12017284 core:OfficeEquipment 2024-12-31 12017284 core:NetGoodwill 2024-12-31 12017284 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 12017284 core:ListedExchangeTraded 2024-12-31 12017284 core:UnlistedNon-exchangeTraded 2024-12-31 12017284 core:LandBuildings 2023-12-31 12017284 core:PlantMachinery 2023-12-31 12017284 core:Vehicles 2023-12-31 12017284 core:FurnitureFittings 2023-12-31 12017284 core:OfficeEquipment 2023-12-31 12017284 core:NetGoodwill 2023-12-31 12017284 core:IntangibleAssetsOtherThanGoodwill 2023-12-31 12017284 core:ListedExchangeTraded 2023-12-31 12017284 core:UnlistedNon-exchangeTraded 2023-12-31 12017284 core:LandBuildings 2024-01-01 2024-12-31 12017284 core:PlantMachinery 2024-01-01 2024-12-31 12017284 core:Vehicles 2024-01-01 2024-12-31 12017284 core:FurnitureFittings 2024-01-01 2024-12-31 12017284 core:OfficeEquipment 2024-01-01 2024-12-31 12017284 core:NetGoodwill 2024-01-01 2024-12-31 12017284 core:IntangibleAssetsOtherThanGoodwill 2024-01-01 2024-12-31 12017284 core:ListedExchangeTraded 2024-01-01 2024-12-31 12017284 core:UnlistedNon-exchangeTraded 2024-01-01 2024-12-31 12017284 core:MoreThanFiveYears 2024-01-01 2024-12-31 12017284 core:Non-currentFinancialInstruments 2024-12-31 12017284 core:Non-currentFinancialInstruments 2023-12-31 12017284 dpl:CostSales 2024-01-01 2024-12-31 12017284 dpl:DistributionCosts 2024-01-01 2024-12-31 12017284 core:LandBuildings 2024-01-01 2024-12-31 12017284 core:PlantMachinery 2024-01-01 2024-12-31 12017284 core:Vehicles 2024-01-01 2024-12-31 12017284 core:FurnitureFittings 2024-01-01 2024-12-31 12017284 core:OfficeEquipment 2024-01-01 2024-12-31 12017284 dpl:AdministrativeExpenses 2024-01-01 2024-12-31 12017284 core:NetGoodwill 2024-01-01 2024-12-31 12017284 core:IntangibleAssetsOtherThanGoodwill 2024-01-01 2024-12-31 12017284 dpl:GroupUndertakings 2024-01-01 2024-12-31 12017284 dpl:ParticipatingInterests 2024-01-01 2024-12-31 12017284 dpl:GroupUndertakings core:ListedExchangeTraded 2024-01-01 2024-12-31 12017284 core:ListedExchangeTraded 2024-01-01 2024-12-31 12017284 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-01-01 2024-12-31 12017284 core:UnlistedNon-exchangeTraded 2024-01-01 2024-12-31 12017284 dpl:CostSales 2023-01-01 2023-12-31 12017284 dpl:DistributionCosts 2023-01-01 2023-12-31 12017284 core:LandBuildings 2023-01-01 2023-12-31 12017284 core:PlantMachinery 2023-01-01 2023-12-31 12017284 core:Vehicles 2023-01-01 2023-12-31 12017284 core:FurnitureFittings 2023-01-01 2023-12-31 12017284 core:OfficeEquipment 2023-01-01 2023-12-31 12017284 dpl:AdministrativeExpenses 2023-01-01 2023-12-31 12017284 core:NetGoodwill 2023-01-01 2023-12-31 12017284 core:IntangibleAssetsOtherThanGoodwill 2023-01-01 2023-12-31 12017284 dpl:GroupUndertakings 2023-01-01 2023-12-31 12017284 dpl:ParticipatingInterests 2023-01-01 2023-12-31 12017284 dpl:GroupUndertakings core:ListedExchangeTraded 2023-01-01 2023-12-31 12017284 core:ListedExchangeTraded 2023-01-01 2023-12-31 12017284 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-01-01 2023-12-31 12017284 core:UnlistedNon-exchangeTraded 2023-01-01 2023-12-31 12017284 core:NetGoodwill 2024-12-31 12017284 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 12017284 core:LandBuildings 2024-12-31 12017284 core:PlantMachinery 2024-12-31 12017284 core:Vehicles 2024-12-31 12017284 core:FurnitureFittings 2024-12-31 12017284 core:OfficeEquipment 2024-12-31 12017284 core:AfterOneYear 2024-12-31 12017284 core:WithinOneYear 2024-12-31 12017284 core:ListedExchangeTraded 2024-12-31 12017284 core:UnlistedNon-exchangeTraded 2024-12-31 12017284 core:ShareCapital 2024-12-31 12017284 core:SharePremium 2024-12-31 12017284 core:RevaluationReserve 2024-12-31 12017284 core:OtherReservesSubtotal 2024-12-31 12017284 core:RetainedEarningsAccumulatedLosses 2024-12-31 12017284 core:NetGoodwill 2023-12-31 12017284 core:IntangibleAssetsOtherThanGoodwill 2023-12-31 12017284 core:LandBuildings 2023-12-31 12017284 core:PlantMachinery 2023-12-31 12017284 core:Vehicles 2023-12-31 12017284 core:FurnitureFittings 2023-12-31 12017284 core:OfficeEquipment 2023-12-31 12017284 core:AfterOneYear 2023-12-31 12017284 core:WithinOneYear 2023-12-31 12017284 core:ListedExchangeTraded 2023-12-31 12017284 core:UnlistedNon-exchangeTraded 2023-12-31 12017284 core:ShareCapital 2023-12-31 12017284 core:SharePremium 2023-12-31 12017284 core:RevaluationReserve 2023-12-31 12017284 core:OtherReservesSubtotal 2023-12-31 12017284 core:RetainedEarningsAccumulatedLosses 2023-12-31 12017284 core:NetGoodwill 2022-12-31 12017284 core:IntangibleAssetsOtherThanGoodwill 2022-12-31 12017284 core:LandBuildings 2022-12-31 12017284 core:PlantMachinery 2022-12-31 12017284 core:Vehicles 2022-12-31 12017284 core:FurnitureFittings 2022-12-31 12017284 core:OfficeEquipment 2022-12-31 12017284 core:AfterOneYear 2022-12-31 12017284 core:WithinOneYear 2022-12-31 12017284 core:ListedExchangeTraded 2022-12-31 12017284 core:UnlistedNon-exchangeTraded 2022-12-31 12017284 core:ShareCapital 2022-12-31 12017284 core:SharePremium 2022-12-31 12017284 core:RevaluationReserve 2022-12-31 12017284 core:OtherReservesSubtotal 2022-12-31 12017284 core:RetainedEarningsAccumulatedLosses 2022-12-31 12017284 core:AfterOneYear 2024-01-01 2024-12-31 12017284 core:WithinOneYear 2024-01-01 2024-12-31 12017284 core:Non-currentFinancialInstruments core:CostValuation 2024-01-01 2024-12-31 12017284 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-01-01 2024-12-31 12017284 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-01-01 2024-12-31 12017284 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-01-01 2024-12-31 12017284 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-01-01 2024-12-31 12017284 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-01-01 2024-12-31 12017284 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-01-01 2024-12-31 12017284 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-01-01 2024-12-31 12017284 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-01-01 2024-12-31 12017284 core:Non-currentFinancialInstruments core:CostValuation 2024-12-31 12017284 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-12-31 12017284 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-12-31 12017284 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-12-31 12017284 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-12-31 12017284 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-12-31 12017284 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-12-31 12017284 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-12-31 12017284 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-12-31 12017284 core:Non-currentFinancialInstruments core:CostValuation 2023-12-31 12017284 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2023-12-31 12017284 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2023-12-31 12017284 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2023-12-31 12017284 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2023-12-31 12017284 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2023-12-31 12017284 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2023-12-31 12017284 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2023-12-31 12017284 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2023-12-31 12017284 bus:Director1 2024-01-01 2024-12-31 12017284 core:FurnitureFittingsToolsEquipment 2023-12-31 12017284 core:FurnitureFittingsToolsEquipment 2024-12-31 12017284 core:FurnitureFittingsToolsEquipment 2024-01-01 2024-12-31

PROCURE MED LTD

Registered Number
12017284
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

PROCURE MED LTD
Company Information
for the year from 1 January 2024 to 31 December 2024

Director | P S Patel

Registered Address | 211 Coldhams Lane
| Cambridge
| CB1 3HY

Registered Number | 12017284 (England and Wales)

PROCURE MED LTD
Balance Sheet as at
31 December 2024

| Notes | 2024 |  | 2023
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 551 |  |  |  | 735
|  |  |  | 551 |  |  |  | 735
Current assets |  |  |  |  |  |  |  |
Debtors | 4 | 9,125 |  |  |  | 13,798 |  |
Cash at bank and on hand |  | 100,117 |  |  |  | 79,541 |  |
|  | 109,242 |  |  |  | 93,339 |  |
Creditors amounts falling due within one year | 5 | (54,538) |  |  |  | (50,298) |  |
Net current assets (liabilities) |  |  |  | 54,704 |  |  |  | 43,041
Total assets less current liabilities |  |  |  | 55,255 |  |  |  | 43,776
Net assets |  |  |  | 55,255 |  |  |  | 43,776
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 1,000 |  |  |  | 1,000
Profit and loss account |  |  |  | 54,255 |  |  |  | 42,776
Shareholders' funds |  |  |  | 55,255 |  |  |  | 43,776

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 29 August 2025, and are signed on its behalf by:
P S Patel Director Registered Company No. 12017284

PROCURE MED LTD
Notes to the Financial Statements
for the year ended 31 December 2024

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Basis of preparation
--- | ---
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling and this is the functional currency of the company.

| Turnover policy
--- | ---
| Turnover represents income receivable in the ordinary course of business for consultancy services, net of discounts and value added taxes. Turnover is recognised when service is provided.

| Current taxation
--- | ---
| Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

| Tangible fixed assets and depreciation
--- | ---
| Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

|  | Reducing balance (%)
| Fixtures and fittings | 25
| Office Equipment | 25

| Financial instruments
--- | ---
| The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. Basic financial liabilities Basic financial liabilities, including creditors are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

| Share capital
--- | ---
| Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.

2. | Average number of employees
--- | ---

|  | 2024 |  | 2023
| Average number of employees during the year | 1 |  | 1

3. | Tangible fixed assets
--- | ---

|  | Fixtures & fittings |  | Office Equipment |  | Total
--- | --- | --- | --- | --- | --- | ---
|  | £ |  | £ |  | £
| Cost or valuation
| At 01 January 24 | 110 |  | 1,168 |  | 1,278
| At 31 December 24 | 110 |  | 1,168 |  | 1,278
| Depreciation and impairment
| At 01 January 24 | 62 |  | 481 |  | 543
| Charge for year | 13 |  | 171 |  | 184
| At 31 December 24 | 75 |  | 652 |  | 727
| Net book value
| At 31 December 24 | 35 |  | 516 |  | 551
| At 31 December 23 | 48 |  | 687 |  | 735

4. | Debtors: amounts due within one year
--- | ---

|  | 2024 |  | 2023
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade debtors / trade receivables | 9,125 |  | 7,050
| Prepayments and accrued income | - |  | 6,748
| Total | 9,125 |  | 13,798

5. | Creditors: amounts due within one year
--- | ---

|  | 2024 |  | 2023
--- | --- | --- | --- | ---
|  | £ |  | £
| Taxation and social security | 12,524 |  | 12,905
| Other creditors | 42,014 |  | 37,393
| Total | 54,538 |  | 50,298

6. | Related party transactions
--- | ---
| Included in other creditors at the year end due within one year is an amount of £42,014 (2023: £36,393) due to the director. During the year the company has declared dividends of £37,200 (2023:£35,000) to the director.